
CHEOY
Healthcare · Medical Devices · $6.69B market cap
$51.18-0.83 (-1.6%)Nov 13, 3:59 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 11, 2026 | After the close | — | 2.47 | — |
| Aug 13, 2025 | Before the open | — | 2.80 | — |
| Feb 13, 2025 | Time not confirmed | — | 3.12 | — |
| Jun 30, 2021 | Time not confirmed | 0.00 | 0.51 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | 0.52 | — |
| Dec 31, 2020 | Time not confirmed | 0.00 | 1.39 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | 1.29 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -2.22 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -1.98 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | 0.96 | — |
| Sep 30, 2019 | Time not confirmed | 0.00 | 0.92 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | 0.90 | — |
| Mar 31, 2019 | Time not confirmed | 0.00 | 0.91 | — |
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System;…
| Dec 31, 2018 |
| Time not confirmed |
| 0.00 |
| 0.79 |
| — |
| Sep 30, 2018 | Time not confirmed | 0.00 | 0.81 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | 0.87 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | 0.90 | — |